Peptide Frequently Asked Questions

---

 Semaglutide is an injectable medication used alongside diet and exercise to help control blood sugar in individuals with type 2 diabetes. It falls under the class of medications known as glucagon-like peptide-1 (GLP-1) agonists, which mimic the hormone GLP-1 in the body to lower blood sugar levels after meals. Semaglutide is available as a once-weekly injection and offers a long-acting option compared to other medications that may require daily administration. Clinical trials have shown that Semaglutide can lead to an average weight loss of 15% in individuals taking it. 

 Tirzepatide is a novel injectable medication used in combination with diet and exercise to improve blood sugar control in individuals with type 2 diabetes. It belongs to a class of medications called glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonists. Tirzepatide works by stimulating the release of insulin and suppressing the hormone glucagon, leading to lower blood sugar levels. It has shown promising results in reducing HbA1c levels and promoting weight loss. 

Clinical trials have shown that people taking Semaglutide can experience significant weight loss. On average, participants in these trials lost around 15% of their initial body weight. However, individual results may vary. It's important to note that weight loss can take time and consistency in using Semaglutide alongside a healthy diet and exercise routine. 

 Tirzepatide is a newer medication that is currently undergoing clinical trials. While specific data on weight loss with Tirzepatide is not yet available, early results from these trials have shown promising weight loss outcomes. Tirzepatide has demonstrated superior weight loss compared to other medications in the same class. Further research is still ongoing to determine the exact amount of weight loss that can be expected with Tirzepatide. 

No, both Semaglutide and Tirzepatide are not types of insulin nor substitutes for insulin. They work differently from insulin. While Semaglutide stimulates the pancreas to release insulin when glucose is present, Tirzepatide works by stimulating the release of insulin and suppressing glucagon. These medications are not used when the pancreas can't produce insulin, such as in type 1 diabetes.
 

 Semaglutide and Tirzepatide, as GLP-1 receptor agonists, not only help control blood sugar but also tend to promote weight loss. These medications slow down the emptying of the stomach, making you feel full for a longer period. They also suppress the release of sugar from the liver and reduce appetite, resulting in reduced food intake and subsequent weight loss. 

 Yes, both Semaglutide and Tirzepatide  help curb appetite. By slowing down gastric emptying and directly regulating appetite, these medications can make you feel fuller for longer and contribute to reduced food intake. 

The time it takes to experience weight loss with Semaglutide or Tirzepatide may vary. In clinical trials, participants gradually increased their dosage over a few weeks to reach the target dose, which resulted in additional weight loss over time. It's important to note that weight loss can take time, and the best results are typically achieved when these medications are used in conjunction with a healthy diet and exercise regimen.
 

Both Semaglutide and Tirzepatide are FDA-approved medications and considered safe and effective when used as indicated. However, like any medication, they do carry certain risks. Semaglutide has a boxed warning regarding the potential occurrence of thyroid C-cell tumors, although the risk in humans is still unknown. It should not be used by individuals with a personal or family history of certain thyroid cancers. Tirzepatide is currently undergoing clinical trials, and its long-term safety is still being evaluated.
 

Common side effects of Semaglutide and Tirzepatide include nausea, vomiting, diarrhea, stomach pain, and constipation. However, adding Vitamin B12 to a GLP-1 agonist like Semaglutide has been shown to reduce nausea and other associated discomfort. It's important to consult with your healthcare provider about any side effects you may experience.
 

While taking Semaglutide or Tirzepatide, it is advisable to limit alcohol consumption, especially if you have diabetes, as alcohol can affect blood sugar levels. Additionally, these medications may impact the absorption of oral medications due to the slowed gastric emptying effect. It is crucial to inform your healthcare provider about all the medications you are taking before starting Semaglutide